(DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 71 | 特発性大腿骨頭壊死症 | 3 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000032412 | 2016/08/21 | 27/04/2018 | Multicenter clinical trial: treatment effect of lansoprazole on non-traumatic osteonecrosis of the femoral head | idiopathic osteonecrosis of the femoral head | Lansoprazole 30mg orally once a day for one year<br>No administration | Sapporo Medical University Hospital | NULL | Complete: follow-up complete | 18years-old | 75years-old | Male and Female | 100 | Phase 2 | Japan | |
| 2 | JPRN-UMIN000009610 | 2012/12/26 | 26/12/2012 | Clinical study for reducing the risk of progress of idiopathic osteonecrosis of the femoral head (ION) by teriparatide treatment | idiopathic osteonecrosis of the femoral head | Teriparatide Acetate<br>Normal treatment | Asahikawa Medical University | NULL | Complete: follow-up complete | 20years-old | Not applicable | Male and Female | 50 | Not selected | Japan | |
| 3 | NCT03112785 (ClinicalTrials.gov) | March 17, 2011 | 7/3/2017 | Fitmore Versus CLS Stem in Total Hip Arthroplasty. Bilateral One-stage Operations | Randomized Comparison Between the Fitmore and the CLS Stem in Patients Operated in One-stage Due to Bilateral Symptomatous Hip Disease | Primary Hip Osteoarthritis;Secondary Hip Osteoarthritis Due to Idiopathic Femoral Head Necrosis, Childhood or Inflammatory Disease;Bilateral Hip Disease;Surgical Treatment | Device: Total hip arthroplasty (Fitmore or CLS uncemented femoral stem made by Zimmer-Biomet, Warshaw, USA) | Sahlgrenska University Hospital, Sweden | Zimmer Biomet | Active, not recruiting | 35 Years | 75 Years | All | 44 | N/A | NULL |